Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Non-Current Debt (2017 - 2022)

Inspire Medical Systems' Non-Current Debt history spans 6 years, with the latest figure at $9.8 million for Q2 2022.

  • On a quarterly basis, Non-Current Debt fell 55.07% to $9.8 million in Q2 2022 year-over-year; TTM through Jun 2022 was $9.8 million, a 55.07% decrease, with the full-year FY2021 number at $15.8 million, down 36.16% from a year prior.
  • Non-Current Debt hit $9.8 million in Q2 2022 for Inspire Medical Systems, down from $12.8 million in the prior quarter.
  • Over the last five years, Non-Current Debt for INSP hit a ceiling of $24.9 million in Q4 2018 and a floor of $9.8 million in Q2 2022.
  • Historically, Non-Current Debt has averaged $22.0 million across 5 years, with a median of $24.4 million in 2019.
  • Biggest five-year swings in Non-Current Debt: soared 51.43% in 2018 and later plummeted 55.07% in 2022.
  • Tracing INSP's Non-Current Debt over 5 years: stood at $24.9 million in 2018, then dropped by 1.62% to $24.5 million in 2019, then increased by 0.91% to $24.7 million in 2020, then plummeted by 36.16% to $15.8 million in 2021, then plummeted by 38.0% to $9.8 million in 2022.
  • Business Quant data shows Non-Current Debt for INSP at $9.8 million in Q2 2022, $12.8 million in Q1 2022, and $15.8 million in Q4 2021.